{"@id":"https://pharmgkb.org/literature/10690840","@context":"https://api.pharmgkb.org/jsonld/literature.jsonld","id":10690840,"resourceId":"20136357","title":"Are patients with intermediate TPMT activity at increased risk of myelosuppression when taking thiopurine medications?","sameAs":"https://www.ncbi.nlm.nih.gov/pubmed/20136357","type":"article"}